Last updated: 22 July 2019 at 6:40am EST

Richard M Johnston Net Worth




The estimated Net Worth of Richard M Johnston is at least $1.62 million dollars as of 10 June 2015. Richard Johnston owns over 20,000 units of Atricure Inc stock worth over $538,000 and over the last 19 years Richard sold ATRC stock worth over $1,079,123.

Richard Johnston ATRC stock SEC Form 4 insiders trading

Richard has made over 8 trades of the Atricure Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently Richard exercised 20,000 units of ATRC stock worth $216,000 on 10 June 2015.

The largest trade Richard's ever made was buying 106,589 units of Atricure Inc stock on 30 May 2007 worth over $1,099,998. On average, Richard trades about 11,899 units every 105 days since 2005. As of 10 June 2015 Richard still owns at least 20,000 units of Atricure Inc stock.

You can see the complete history of Richard Johnston stock trades at the bottom of the page.



What's Richard Johnston's mailing address?

Richard's mailing address filed with the SEC is 500 E Pratt St # 1200, Baltimore, MD 21202, USA.

Insiders trading at Atricure Inc

Over the last 19 years, insiders at Atricure Inc have traded over $52,789,242 worth of Atricure Inc stock and bought 666,621 units worth $5,937,195 . The most active insiders traders include Scott William Drake, Group I, Llc Donoghue Danie... et Management Group Viii L L C.... On average, Atricure Inc executives and independent directors trade stock every 24 days with the average trade being worth of $548,410. The most recent stock trade was executed by Maggie Yuen on 15 August 2024, trading 3,500 units of ATRC stock currently worth $84,245.



What does Atricure Inc do?

atricure, inc. provides innovative technologies for the treatment of afib and related conditions. afib affects more than 33 million people worldwide. electrophysiologists and cardiothoracic surgeons around the globe use atricure technologies for the treatment of afib and reduction of afib related complications. atricure’s isolator® synergy™ ablation system is the first and only medical device to receive fda approval for the treatment of persistent afib. atricure’s atriclip left atrial appendage exclusion system products are the most widely sold laa management devices worldwide, with more than 100,000 implanted to date. for more information, visit atricure.com or follow us on twitter @atricure.



Complete history of Richard Johnston stock trades at Atricure Inc

Initié
Trans.
Transaction
Prix ​​total
Richard M Johnston
Directeur
Exercice d'option $216,000
10 Jun 2015
Richard M Johnston
Directeur
Exercice d'option $876,009
30 Jan 2014
Richard M Johnston
Directeur
Vente $28,309
8 Mar 2011
Richard M Johnston
Directeur
Vente $128,379
4 Mar 2011
Richard M Johnston
Directeur
Vente $455,676
2 Mar 2011
Richard M Johnston
Directeur
Vente $213,312
28 Feb 2011
Richard M Johnston
Directeur
Vente $253,448
24 Feb 2011
Richard M Johnston
Directeur
Acheter $1,099,998
30 May 2007


Atricure Inc executives and stock owners

Atricure Inc executives and other stock owners filed with the SEC include: